BiomX Inc. (PHGE) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the NYSE. With a market capitalization of $7 million, BiomX Inc. is a micro-cap company. The stock currently trades at $4.30, down 1.60% today, with a 52-week range of $1.50–$14.71.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $22.19 | $22.19 | +560.4% | |
| 2024 | $3.36 | $1.47 | +558.8% | |
| 2023 | $0.51 | $0.51 | -46.3% | |
| 2022 | $0.95 | $0.95 | — | |
| 2021 | — | — | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-19 | 0001213900-26-018231 | SEC ↗ |
| 2024-12-31 | 2025-03-25 | 0001013762-25-002283 | SEC ↗ |
| 2023-12-31 | 2024-04-04 | 0001213900-24-030053 | SEC ↗ |
| 2022-12-31 | 2023-03-29 | 0001213900-23-024122 | SEC ↗ |
| 2021-12-31 | 2022-03-30 | 0001213900-22-016136 | SEC ↗ |
| 2020-12-31 | 2021-03-31 | 0001213900-21-019233 | SEC ↗ |
| 2019-12-31 | 2020-03-26 | 0001213900-20-007405 | SEC ↗ |
| 2019-06-30 | 2019-08-21 | 0001213900-19-016461 | SEC ↗ |